Metallointercalator [Ru(dppz)2(PIP)]2+ renders BRCA wild-type triple-negative breast cancer cells hypersensitive to PARP inhibition
There is a need to improve and extend the use of clinically approved poly(ADP-ribose) polymerase (PARP) inhibitors (PARPi), including for BRCA wild-type triple-negative breast cancer (TNBC). The demonstration that ruthenium(II) polypyridyl complex (RPC) metallointercalators can rapidly stall DNA rep...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Статья |
| Язык: | English |
| Опубликовано: |
American Chemical Society
2020
|
| Online-ссылка: | http://psasir.upm.edu.my/id/eprint/86732/1/Metallointercalator.pdf |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
